NEW YORK, Feb. 16 (GenomeWeb News) - Vala Sciences will now begin to sell cell image-based reagents and analysis software tools for academic, pharmaceutical, and biotech scientists, the company said today.
The LaJolla, Calif.-based start-up, less than a year old, also announced that it is starting off with $3.5 million in funding from the National Institutes of Health, the California Technology Investment Partnership Program, and private individual investors.
Vala's core team, headed by CEO Jeffrey Price, said that its automated technology would save researchers weeks of time when analyzing images attained by fluorescence-based microscopy. Price formerly developed software for microscopy analysis for Q3DM.
According to Vala, collaborations have already been initiated with the Chemical Genomics Research Consortium of the Gulf Coast Consortia, The Burnham Institute, Regenemed, and the